← Leaderboards
Sally Choate Kent
Univ Of Massachusetts Med Sch Worcester
$5,343,871
Attributed
$14,399,590
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,399,590 · 7
By mechanism
R01$5,957,453 · 2
U01$4,090,869 · 1
UC4$1,972,347 · 1
P50$1,918,296 · 2
R21$460,625 · 1
Top collaborators
- Michael Birnbaum4 shared
- Michael Allen Brehm4 shared
- Curtis Lisante Cetrulo4 shared
- George Q Daley4 shared
- Dale L Greiner4 shared
- Rene Maehr4 shared
- Helena Kristiina Reijonen4 shared
- Leonard D. Shultz4 shared
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- John E Harris$6,909,265
- Katherine F Luzuriaga$51,194,887
- Manuel Garber$10,924,566
- David Marshall Harlan$3,146,690
- Mehdi Rashighi$2,140,335
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteInsulin-Dependent Diabetes MellitusCellsIsletAutoreactive T CellAntigensSignal TransductionSourceIn VitroTissuesAnimal ModelImmuneIn VivoMediatingAutoimmune DiseasesRecruitBeta CellCell CommunicationAutoantigensInsulinCell LineCell TypeDiabetes MellitusDesign
Grant awards (19)
Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands$764,333
R01 · FY2025 · DK
Extracellular Vesicle-mediated islet immune cross talk in Type 1 Diabetes pathogenesis$747,900
R01 · FY2025 · DK
Autoreactive T Cell Function in Vitiligo$397,485
P50 · FY2025 · AR · contact PI
Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands$769,703
R01 · FY2024 · DK
Extracellular Vesicle-mediated islet immune cross talk in Type 1 Diabetes pathogenesis$751,132
R01 · FY2024 · DK
Autoreactive T Cell Function in Vitiligo$506,937
P50 · FY2024 · AR · contact PI
Extracellular Vesicle-mediated islet immune cross talk in Type 1 Diabetes pathogenesis$751,132
R01 · FY2023 · DK
Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands$674,605
R01 · FY2023 · DK
Autoreactive T Cell Function in Vitiligo$506,937
P50 · FY2023 · AR · contact PI
Humanized Mouse Avatars for T1D$1,005,973
U01 · FY2022 · DK
Extracellular Vesicle-mediated islet immune cross talk in Type 1 Diabetes pathogenesis$770,132
R01 · FY2022 · DK
Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands$728,516
R01 · FY2022 · DK
Autoreactive T Cell Function in Vitiligo$506,937
P50 · FY2022 · AR · contact PI
Humanized Mouse Avatars for T1D$1,008,786
U01 · FY2021 · DK
Humanized Mouse Avatars for T1D$1,011,466
U01 · FY2020 · DK
Humanized Mouse Avatars for T1D$1,064,644
U01 · FY2019 · DK
Human Islet-Infiltrating T Cell Biology: Reactivity, Structure, and Function$1,972,347
UC4 · FY2017 · DK · contact PI
Human islet-derived, islet-reactive T cells from subjects with Type 1 diabetes$209,375
R21 · FY2017 · AI · contact PI
Human islet-derived, islet-reactive T cells from subjects with Type 1 diabetes$251,250
R21 · FY2016 · AI · contact PI